Polymetastatic Lesion Ablative Radiotherapy with Immunotherapy Study (POLARIS): A ctDNA-Guided Phase II Trial for Patients with Metastatic Advanced Solid Tumors
Year: 2026
Type: article
Study design: Study Protocol
Institutions: University of Chicago, University of Illinois Chicago
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: polymetastatic disease, stereotactic body radiotherapy, immunotherapy, circulating tumor DNA, early response biomarkers, oligometastatic disease, advanced solid tumors, molecular response, oligoprogression, treatment de-escalation, immune checkpoint inhibitors, PD-1/PD-L1 inhibitors, CTLA-4 inhibitors
Open Access status: closed
OpenAlex ID: W7214400289
